Compare BIO & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | BEP |
|---|---|---|
| Founded | 1952 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electric Utilities: Central |
| Sector | Industrials | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.1B |
| IPO Year | N/A | N/A |
| Metric | BIO | BEP |
|---|---|---|
| Price | $269.07 | $30.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $358.50 | $34.30 |
| AVG Volume (30 Days) | 304.0K | ★ 592.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.51 | $14.36 |
| Revenue Next Year | $3.17 | N/A |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $19.29 |
| 52 Week High | $343.12 | $32.78 |
| Indicator | BIO | BEP |
|---|---|---|
| Relative Strength Index (RSI) | 37.86 | 50.59 |
| Support Level | $266.71 | $24.57 |
| Resistance Level | $290.01 | $32.75 |
| Average True Range (ATR) | 7.21 | 0.79 |
| MACD | 0.67 | -0.29 |
| Stochastic Oscillator | 13.13 | 42.94 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.